|
NOTE 2—ACQUISITION
On May 24, 2010, the Company completed the acquisition of substantially all of the assets (92 theatres and 928 screens) of Kerasotes Showplace Theatres, LLC ("Kerasotes"). Kerasotes operated 95 theatres and 972 screens in mid-sized, suburban and metropolitan markets, primarily in the Midwest. The acquisition of Kerasotes was treated as a purchase in accordance with Accounting Standards Codification, ("ASC") 805, Business Combinations. The total purchase price for the Kerasotes theatres was $281,415,000. Results of operations of Kerasotes are included in the Company's Consolidated Statements of Operations from May 24, 2010.
During fiscal 2011, in connection with the acquisition of Kerasotes, the Company divested of seven Kerasotes theatres with 85 screens as required by the Antitrust Division of the United States Department of Justice. The Company was also required by the Antitrust Division of the United States Department of Justice to divest of four AMC theatres with 57 screens. Additionally, the Company acquired two theatres with 26 screens that were received in exchange for three of the AMC theatres with 43 screens.
The following unaudited pro forma information summarizes the results of operations as if the Kerasotes acquisition and the required divestitures had occurred as of the beginning of fiscal 2011:
|
|
|
|
|
|
|
|
|
(In thousands) |
|
Pro forma
Thirteen Weeks
Ended
September 30,
2010 |
|
Pro forma
Twenty-six Weeks
Ended
September 30,
2010 |
|
|
|
(unaudited)
|
|
(unaudited)
|
|
|
Total revenues |
|
$ |
651,783 |
|
$ |
1,323,164 |
|
|
Net earnings |
|
|
60,138 |
|
|
64,131 |
|
|